Skip to main content

SQZ Biotechnologies Company (SQZ)

NYSE: SQZ · IEX Real-Time Price · USD
12.28 -0.98 (-7.39%)
Nov 26, 2021 1:00 PM EST - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Year202020192018
Revenue
2120.1112.67
Revenue Growth
4.42%58.73%-
Gross Profit
2120.1112.67
Selling, General & Admin
20.5118.278.69
Research & Development
51.5536.124.38
Operating Expenses
72.0654.3733.07
Operating Income
-51.06-34.27-20.4
Interest Expense / Income
000.06
Other Expense / Income
-0.54-2.06-1.21
Pretax Income
-50.52-32.2-19.25
Net Income
-50.52-32.2-19.25
Preferred Dividends
000.98
Net Income Common
-50.52-32.2-20.23
Shares Outstanding (Basic)
522
Shares Outstanding (Diluted)
522
Shares Change
216.92%7.43%-
EPS (Basic)
-9.35-18.89-12.75
EPS (Diluted)
-9.35-18.89-12.75
Free Cash Flow Per Share
-8.21-20.9212.47
Gross Margin
100.00%100.00%100.00%
Operating Margin
-243.16%-170.40%-161.05%
Profit Margin
-240.60%-160.14%-151.95%
Free Cash Flow Margin
-211.11%-177.33%156.22%
EBITDA
-39.58-27.85-18.12
EBITDA Margin
-188.48%-138.48%-143.06%
EBIT
-50.52-32.2-19.19
EBIT Margin
-240.60%-160.14%-151.48%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).